Read + Share
Furstenau M, Thus YJ, Robrecht S, Mellink CHM, et al. High karyotypic complexity is an independent prognostic factor in patients with
CLL treated with venetoclax combinations. Blood 2023;142:446-459.
PMID: 37172204
|
 |
|
Furstenau M, Thus YJ, Robrecht S, Mellink CHM, et al. High karyotypic complexity is an independent prognostic factor in patients with
CLL treated with venetoclax combinations. Blood 2023;142:446-459.
PMID: 37172204
|
|
|
|